Front Row Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-27
| Closed | -$10K | – | 943 |
|
2021
Q2 | $10K | Sell |
27
-34
| -56% | -$12.6K | ﹤0.01% | 563 |
|
2021
Q1 | $22K | Sell |
61
-10
| -14% | -$3.61K | 0.01% | 383 |
|
2020
Q4 | $23K | Sell |
71
-2
| -3% | -$648 | 0.01% | 360 |
|
2020
Q3 | $23K | Buy |
73
+33
| +83% | +$10.4K | 0.01% | 354 |
|
2020
Q2 | $11K | Hold |
40
| – | – | 0.01% | 444 |
|
2020
Q1 | $11K | Buy |
40
+9
| +29% | +$2.48K | 0.01% | 446 |
|
2019
Q4 | $9K | Sell |
31
-1
| -3% | -$290 | 0.01% | 475 |
|
2019
Q3 | $8K | Buy |
32
+10
| +45% | +$2.5K | 0.01% | 480 |
|
2019
Q2 | $6K | Sell |
22
-2
| -8% | -$545 | ﹤0.01% | 540 |
|
2019
Q1 | $7K | Sell |
24
-3
| -11% | -$875 | 0.01% | 502 |
|
2018
Q4 | $7K | Hold |
27
| – | – | 0.01% | 468 |
|
2018
Q3 | $7 | Buy |
27
+3
| +13% | +$1 | ﹤0.01% | 484 |
|
2018
Q2 | $6 | Hold |
24
| – | – | ﹤0.01% | 544 |
|
2018
Q1 | $5K | Buy |
24
+13
| +118% | +$2.71K | ﹤0.01% | 558 |
|
2017
Q4 | $2K | Buy |
+11
| New | +$2K | ﹤0.01% | 668 |
|